The digital diabetes care market forecast

Research2Guidance: The digital diabetes care to reach $1.5B in 2024

This year, it is expected to exceed $742M, growing at an average CAGR of 50% annually.
telehealth survey

Survey: 44% of Americans have used telehealth during COVID-19 pandemic

The data reveals multitasking during appointments, including checking social media and playing video games.
digital therapeutics

Juniper: There will be 1.4B digital therapeutics and wellness app users by 2025

The growth comes after regulators responded to COVID-19 by loosening rules that had previously hindered the work of digital therapeutics developers.
Rock Health: Market Insights

Rock: Digital health companies hit a new record in Q3 2020

With 24 mega-deals so far, 2020 will be the largest funding year ever for digital health...
StartUp Health Q3 2020

StartUp Health: Digital health startups attract $6.6B in Q3 2020

It brings 2020's year-to-date funding total to around $16B, more than any previous full year on record.
wearables

IDC: 336.5M wearable devices shipped in 2019

The worldwide market for wearable devices grew 82.3% in the fourth quarter of 2019 (4Q19), reaching a new high of 118.9 million devices shipped.
Healthcare Reimagined

Mangrove Capital: Industry outsiders will reinvent healthcare

The firm's report has found that of the top 50 medical apps by monthly active users (MAU), none were conceived and built by doctors.
IDC: Apple dominated the wearables market in Q3 2019

IDC: Apple dominated the wearables market in Q3 2019

Worldwide wearables shipments surge 94.6% in the quarter led by the hearables market.
health wearables

GlobalData: $54B wearable tech industry offers immense opportunity for healthcare by 2023

Wearables have the greatest potential in healthcare to address spiraling healthcare costs, aging populations, and the burden of chronic disease.
Global wearable tech revenue 2018-2023

Research: $54bn wearable tech industry offers immense opportunity for healthcare by 2023

However, there are many barriers that must be overcome before widespread adoption including cost, reimbursement, data quality and lack of clinical evidence.